Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Are Drug-Drug Interactions Today’s Biggest Health Threat?

Posted on October 16th, 2018 by

Pharma R&D

drug interaction new

The use of prescription medicines is sharply on the rise. Over the past decade, the number of adults taking over-the-counter medicines has sunk, while the number of prescription drug users has increased by more than 30 percent. Continue reading “Are Drug-Drug Interactions Today’s Biggest Health Threat?” »

Human Cells + Tech = Accelerated Drug Development and Treatment

Posted on October 16th, 2018 by

Pharma R&D

bioprinting new

Some scientific advancements can be both awe-inspiring and just a little creepy at the same time. In the world of pharma and medicine, this applies to some newer approaches that are melding living cells with high-tech to do some wonderful things. Two such advances, which made the short list for BiopharmaTrend.com’s top trends in pharmaceutical research for 2018, are organs-on-chips and bioprinting. Continue reading “Human Cells + Tech = Accelerated Drug Development and Treatment” »

Using data for good to solve humanitarian issues

Posted on October 16th, 2018 by

Pharma R&D

using data new

Researchers are increasingly using their domain expertise to tackle many of the world’s problems such as hunger, pandemics and other societal issues. When I worked for a pharma company I was continually surprised experienced pharmacologists could tell me which toxicology events in animals were predictive of human responses and which events could be safely ignored. Continue reading “Using data for good to solve humanitarian issues” »

How Drug Repurposing Is Revitalizing the Pharma Industry

Posted on October 16th, 2018 by

Pharma R&D

drug repurposing new

The average expense of bringing a new drug to market has increased by more than 200 percent since the 1990s, with development costs regularly running into the billions. As pharma revenues continue to sink below the costs of creating commercially viable drugs, a growing number of developers are exploring a different approach: seeking out additional monetizable uses for drugs to which they already own intellectual property rights. Continue reading “How Drug Repurposing Is Revitalizing the Pharma Industry” »

Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better

Posted on October 16th, 2018 by

Pharma R&D

dna

Genetic testing has become a big hit with consumers. Companies like Ancestry.com and 23andMe flood the airwaves with commercials about the joy of using DNA testing to find out about your heritage. But another reason genetic testing is attracting consumers is because it also can tell people about some of their genetic health risks. Continue reading “Drawbacks of Consumer Genetic Testing – And What Pharma Can Do To Make It Better” »

The Delicate Balance of Drug Risks vs. Benefits

Posted on October 16th, 2018 by

Pharma R&D

Pills

For many people, taking medication is a regular part of their daily routine, and these medicines are relied upon to treat disease and improve health.  The benefits of medicines are the helpful effects you get when you use them, such as the lowering blood pressure, curing infection, or relieving pain. Continue reading “The Delicate Balance of Drug Risks vs. Benefits” »

  1. 1
  2. 2
  3. 3
  4. 57


About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.